S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The Gold Story No One's Telling (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The Gold Story No One's Telling (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The Gold Story No One's Telling (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The Gold Story No One's Telling (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

First Wave BioPharma (FWBI) Short Interest Ratio & Short Volume

$5.10
+0.14 (+2.82%)
(As of 02/22/2024 ET)

First Wave BioPharma Short Interest Data

Current Short Volume
176,600 shares
Previous Short Volume
126,400 shares
Change Vs. Previous Month
+39.72%
Dollar Volume Sold Short
$935,980.00
Short Interest Ratio / Days to Cover
0.3
Last Record Date
January 31, 2024
Outstanding Shares
680,000 shares
Float Size
615,500 shares
Short Percent of Float
28.69%
Today's Trading Volume
31,628 shares
Average Trading Volume
416,590 shares
Today's Volume Vs. Average
8%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling First Wave BioPharma ?

Sign up to receive the latest short interest report for First Wave BioPharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FWBI Short Interest Over Time

FWBI Days to Cover Over Time

FWBI Percentage of Float Shorted Over Time


First Wave BioPharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024176,600 shares $935,980.00 +39.7%28.7%0.3 $5.30
1/15/2024126,400 shares $511,920.00 -65.6%19.3%0.2 $4.05
12/31/2023367,800 shares $1.54 million +2,914.8%54.5%0.6 $4.20
12/15/202312,200 shares $53,899.60 -96.2%1.8%0 $4.42
11/30/2023317,300 shares $87,194.04 +45.9%2.4%0.1 $0.27
11/15/2023217,500 shares $58,551.00 +52.7%1.6%0.1 $0.27
10/31/2023142,400 shares $41,110.88 +37.6%1.1%0 $0.29
10/15/2023103,500 shares $36,276.75 -36.2%0.8%0 $0.35
9/30/2023162,100 shares $47,009.00 -45.6%1.2%0 $0.29
9/15/2023297,700 shares $130,988.00 +1,253.2%4.2%0.1 $0.44
8/31/202322,000 shares $6,820.00 -37.7%0.3%0 $0.31
8/15/202335,300 shares $14,942.49 -22.4%0.5%0 $0.42
7/31/202345,500 shares $24,902.15 -91.2%1.1%0 $0.55
7/15/2023514,200 shares $488,490.00 +143.1%12.2%0.3 $0.95
6/30/2023211,500 shares $338,400.00 -79.9%5.0%0.1 $1.60
6/15/20231,050,000 shares $2.00 million +1,701.0%24.9%0.7 $1.90
5/31/202358,300 shares $108,438.00 +4.7%3.2%0.6 $1.86
5/15/202355,700 shares $151,504.00 +19.8%3.1%0.7 $2.72
4/30/202346,500 shares $135,315.00 -33.6%3.1%0.5 $2.91
4/15/202370,000 shares $184,800.00 +31.6%4.7%0.2 $2.64
3/31/202353,200 shares $142,576.00 -27.4%3.7%0.1 $2.68
3/15/202373,300 shares $218,434.00 -4.4%4.7%0.1 $2.98
2/28/202376,700 shares $273,052.00 -19.3%9.3%0.2 $3.56
2/15/202395,000 shares $360,050.00 -30.9%11.5%0.2 $3.79
1/31/2023137,500 shares $745,250.00 +500.4%16.6%0.3 $5.42
1/15/202322,900 shares $14,882.71 -62.5%2.8%0.1 $0.65
12/30/202261,000 shares $53,411.60 -65.0%1.1%0.1 $0.88
12/15/2022174,100 shares $104,477.41 -52.7%3.0%0.2 $0.60
11/30/2022368,400 shares $305,772.00 -31.1%6.4%0.5 $0.83
11/15/2022534,500 shares $475,865.35 +105.3%9.3%0.4 $0.89
10/31/2022260,400 shares $286,440.00 +90.1%18.9%0.2 $1.10
10/15/2022137,000 shares $153,440.00 -64.4%9.9%0.2 $1.12
9/30/2022384,300 shares $568,764.00 +176.5%27.9%0.4 $1.48
9/15/2022139,000 shares $283,560.00 +160.3%10.1%0.2 $2.04
8/31/202253,400 shares $163,938.00 -93.6%3.9%0.1 $3.07
8/15/2022836,800 shares $143,009.12 -1.0%2.0%0.3 $0.17
7/31/2022844,900 shares $124,284.79 -34.0%4.0%0.3 $0.15
7/15/20221,280,000 shares $200,960.00 +247.2%6.0%0.5 $0.16
6/30/2022368,700 shares $73,740.00 +23.3%1.7%0.3 $0.20
6/15/2022299,100 shares $89,730.00 -22.9%1.4%0.3 $0.30













FWBI Short Interest - Frequently Asked Questions

What is First Wave BioPharma's current short interest?

Short interest is the volume of First Wave BioPharma shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 176,600 shares of FWBI short. 28.69% of First Wave BioPharma's shares are currently sold short. Learn More on First Wave BioPharma's current short interest.

What is a good short interest percentage for First Wave BioPharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 28.69% of First Wave BioPharma's floating shares are currently sold short.

Is First Wave BioPharma's short interest increasing or decreasing?

First Wave BioPharma saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 176,600 shares, an increase of 39.7% from the previous total of 126,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is First Wave BioPharma's float size?

First Wave BioPharma currently has issued a total of 680,000 shares. Some of First Wave BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. First Wave BioPharma currently has a public float of 615,500 shares.

How does First Wave BioPharma's short interest compare to its competitors?

28.69% of First Wave BioPharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to First Wave BioPharma: Ainos, Inc. (1.66%), Petros Pharmaceuticals, Inc. (18.79%), Jaguar Health, Inc. (10.15%), Onconetix, Inc. (7.12%), PainReform Ltd. (0.27%), Virpax Pharmaceuticals, Inc. (0.82%), LumiraDx Limited (2.89%), Agile Therapeutics, Inc. (6.71%), Processa Pharmaceuticals, Inc. (12.47%), Ensysce Biosciences, Inc. (23.32%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short First Wave BioPharma stock?

Short selling FWBI is an investing strategy that aims to generate trading profit from First Wave BioPharma as its price is falling. FWBI shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against First Wave BioPharma?

A short squeeze for First Wave BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FWBI, which in turn drives the price of the stock up even further.

How often is First Wave BioPharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FWBI, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:FWBI) was last updated on 2/23/2024 by MarketBeat.com Staff